Marjan Azin, MD is a postdoctoral research fellow at the Center for Cancer Immunology and Cutaneous Biology Research Center at Massachusetts General Hospital. Dr. Azin obtained her medical degree from the Tehran University of Medical Science. She joined the Demehri lab in 2019 to study the role of immune cells and alarmin cytokines in preventing cancer development. She is working on the role of topical immunotherapy for skin cancer prevention in organ transplant recipients as well as treatment of the early stages of skin and breast cancer. In addition, Dr. Azin is investigating the role of epithelial-derived cytokines in breast gland differentiation. She is leading the laboratory investigation into the mechanisms of cutaneous immune-related Adverse Events (irAEs) in cancer patients who are on immune checkpoint inhibitor therapy as part of the Skin irAEs Program at the Cutaneous Biology Research Center at Massachusetts General Hospital.